Abilify sedating effect
Aripiprazole is an antipsychotic drug with an important We searched the Cochrane Schizophrenia Group Trials Register (November 2012), inspected references of all identified studies for further trials and contacted relevant pharmaceutical companies, drug approval agencies and authors of trials for additional information.
We now have included 174 trials involving 17,244 participants.
No matter what your age, before you take an antidepressant, you, your parent, or your caregiver should talk to your doctor about the risks and benefits of treating your condition with an antidepressant or with other treatments.
You should also talk about the risks and benefits of not treating your condition.
Talk to your doctor about your condition, symptoms, and personal and family medical history.
You and your doctor will decide what type of treatment is right for you.
Be sure that your family or caregiver knows which symptoms may be serious so they can call the doctor if you are unable to seek treatment on your own.
However, people with schizophrenia as well as mental health professionals and policy makers should know that the evidence is limited and mostly of low or very low quality.
More trials and Information on all comparisons is of limited quality, is incomplete and problematic to apply clinically.
The quality of the evidence is all low or very low.
Be sure to keep all appointments for office visits with your doctor.
The doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with aripiprazole.